AI eye for colonoscopy: could software catch what doctors miss?

NCT ID NCT07744607

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This trial evaluates an AI-based software tool designed to assist doctors in interpreting colonoscopy images. Using previously collected images and biopsy results from over a thousand patients, the study checks how accurately the AI classifies colorectal lesions as cancerous, precancerous, or benign. The goal is to see if this technology can reliably support doctors in detecting and assessing colorectal conditions during endoscopic exams.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Artificial intelligence-based medical device software (ENAD-CADx-01) for endoscopic imaging assistance
What this could lead to
If proven accurate, this AI tool could help doctors better identify and classify colorectal lesions during colonoscopy, potentially improving early detection of cancer and reducing unnecessary biopsies.
What could go wrong
This is a retrospective study using stored images, not a real-time test. The AI's performance may differ in live procedures, and it may not generalize to other hospitals or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLONIC POLYPS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Asan Medical Center

    Seoul, Seoul, 05505, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.